<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A case of skin <z:mp ids='MP_0001651'>necrosis</z:mp> in a patient receiving intravenous (IV) <z:chebi fb="5" ids="28304">heparin</z:chebi> during routine intermittent hemodialysis is reported </plain></SENT>
<SENT sid="1" pm="."><plain>Multiple erythematous, tender lesions developed over the abdomen and thighs and rapidly became necrotic </plain></SENT>
<SENT sid="2" pm="."><plain>Biopsies showed fibrin <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in the dermal venules and capillaries, but no cellular infiltrate </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was in her third month of regular hemodialysis </plain></SENT>
<SENT sid="4" pm="."><plain>Skin <z:mp ids='MP_0001651'>necrosis</z:mp> associated with the use of <z:chebi fb="5" ids="28304">heparin</z:chebi> usually occurs within 2 weeks of beginning <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy and has not been reported in patients receiving <z:chebi fb="5" ids="28304">heparin</z:chebi> with hemodialysis </plain></SENT>
<SENT sid="5" pm="."><plain>Possible mechanisms, including acquired <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> leading to <z:chebi fb="5" ids="28304">heparin</z:chebi>-induced skin <z:mp ids='MP_0001651'>necrosis</z:mp>, are discussed </plain></SENT>
</text></document>